Outcome of reclassification of world health organization (WHO) class III under international society of nephrology-renal pathology society (ISN-RPS) classification: Retrospective observational study

Rheumatology International

Volumn 32, Issue 7, 2012, Pages 1877-1884

  Hwang, Jiwon ^a   Kim, Hyung Jin ^a   Oh, Ji Min ^a   Ahn, Joong Kyong ^b   Lee, Yoo Sun ^a   Lee, Jaejoon ^a   Kim, Yoon Goo ^a   Huh, Woo Sung ^a   Seo, Jinwon ^c   Koh, Eun Mi ^a   Cha, Hoon Suk ^a  

^a Sungkyunkwan University   (South Korea)

^b School of Medicine   (South Korea)

^c Hallym University College of Medicine   (South Korea)

Author keywords

Class switching event; ISN RPS classification; Lupus nephritis; Renal outcome; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE GLOMERULONEPHRITIS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEMODIALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTERNATIONAL SOCIETY OF NEPHROLOGY RENAL PATHOLOGY SOCIETY CLASSIFICATION; KIDNEY BIOPSY; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEPHROTIC SYNDROME; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE; UROGENITAL TRACT MALFORMATION; WORLD HEALTH ORGANIZATION CLASS III CLASSIFICATION;

ADULT; CYCLOPHOSPHAMIDE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERNATIONAL CLASSIFICATION OF DISEASES; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREDNISOLONE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84863988122     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1887-x     Document Type: Article

References (24)

1. Balow JE, Boumpas DT, Austin HA III (1999) Systemic lupus erythematosus and the kidney. In: Lahita R (ed) Systemic lupus erythematosus, 3rd edn. Academic Press, San Diego, pp 657-685
2. McCluskey R (1975) Kidney pathology decennial: 1966-1975. In: Sommers S (ed) Appelton Century Crofts, East Norwalk, p 435
3. Austin HA III, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75:382-391 (Pubitemid 13005770)
4. Tateno S, Kobayashi Y, Shigematsu H, Hiki Y (1983) Study of lupus nephritis: Its classification and the significance of subendothelial deposits. Q J Med 52:311-331 (Pubitemid 14238627)
5. Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J (2001) Significance of histologic patterns of glomerular injury upon long-Term prognosis in severe lupus glomerulonephritis. Kidney Int 59:2156-2163 (Pubitemid 32467607)
6. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521-530 (Pubitemid 38130646)
7. Kim YG, Kim HW, Cho YM, Oh JS, Nah SS, Lee CK, Yoo B (2008) The difference between lupus nephritis class IV-G and IV-S in Koreans: Focus on the response to cyclophosphamide induction treatment. Rheumatology (Oxford) 47:311-314 (Pubitemid 351267197)
8. Hiramatsu N, Kuroiwa T, Ikeuchi H, Maeshima A, Kaneko Y, Hiromura K, Ueki K, Nojima Y (2008) Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. Rheumatology (Oxford) 47:702-707 (Pubitemid 351619216)
9. Hill GS, Delahousse M, Nochy D, Bariety J (2005) Class IV-S versus class IV-G lupus nephritis: Clinical and morphologic differences suggesting different pathogenesis. Kidney Int 68: 2288-2297 (Pubitemid 43117806)
10. Yokoyama H, Wada T, Hara A, Yamahana J, Nakaya I, Kobayashi M, Kitagawa K, Kokubo S, Iwata Y, Yoshimoto K, Shimizu K, Sakai N, Furuichi K (2004) The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese. Kidney Int 66:2382-2388
11. Mittal B, Hurwitz S, Rennke H, Singh AK (2004) New subcategories of class IV lupus nephritis: Are there clinical, histologic, and outcome differences? Am J Kidney Dis 44:1050-1059 (Pubitemid 39556485)
12. Seo J (2008) Pathology of lupus nephritis is better classified by the International Society of Nephrology-Renal Pathology Society system. Basic Appl Pathol 1:12-17
13. Mosca M, Pasquariello A, Tavoni A, Moriconi L, Moneta I, Innocenti M, Bencivelli W, Bombardieri S (1997) Predictors of renal outcome in diffuse proliferative glomerulonephritis in systemic lupus erythematosus. Lupus 6:371-378 (Pubitemid 27232131)
14. Contreras G, Pardo V, Cely C, Borja E, Hurtado A, De La Cuesta C, Iqbal K, Lenz O, Asif A, Nahar N, Leclerq B, Leon C, Schulman I, Ramirez-Seijas F, Paredes A, Cepero A, Khan T, Pachon F, Tozman E, Barreto G, Hoffman D, Almeida Suarez M, Busse JC, Esquenazi M, Esquenazi A, Garcia Mayol L, Garcia Estrada H (2005) Factors associated with poor outcomes in patients with lupus nephritis. Lupus 14:890-895 (Pubitemid 41736370)
15. Steinberg AD, Steinberg SC (1991) Long-Term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 34:945-950
16. Gourley MF, Austin HA III, Scott D, Yarboro CH, Vaughan EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD (1996) Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med 125:549-557 (Pubitemid 126450087)
17. Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Steinberg AD, Klippel JH, Balow JE, Boumpas DT (2001) Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-Term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med 135:248-257 (Pubitemid 32799338)
18. Illei GG, Takada K, Parkin D, Austin HA, Crane M, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Pando J, Steinberg AD, Gourley MF, Klippel JH, Balow JE, Boumpas DT (2002) Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: Longterm followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum 46:995-1002 (Pubitemid 34303812)
19. Ponticelli C, Zucchelli P, Moroni G, Cagnoli L, Banfi G, Pasquali S (1987) Long-Term prognosis of diffuse lupus nephritis. Clin Nephrol 28:263-271 (Pubitemid 18018705)
20. Moroni G, Quaglini S, Gallelli B, Banfi G, Messa P, Ponticelli C (2007) The long-Term outcome of 93 patients with proliferative lupus nephritis. Nephrol Dial Transplant 22:2531-2539 (Pubitemid 47365517)
21. Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC (2006) Long-Term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Am J Med 119:355 e325-e333
22. Mok CC, Ho CT, Chan KW, Lau CS, Wong RW (2002) Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine. Arthritis Rheum 46:1003-1013 (Pubitemid 34303813)
23. Chan TM, Tse KC, Tang CS, Lai KN, Li FK (2005) Long-Term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine. Lupus 14:265-272 (Pubitemid 40559171)
24. Boumpas DT, Balow JE (1998) Outcome criteria for lupus nephritis trials: A critical overview. Lupus 7:622-629 (Pubitemid 29008229)